Condition 1: General symptoms and signs. Condition 2: General symptoms and signs. Condition 3: General symptoms and signs. Condition 4: General symptoms and signs. Condition 5: General symptoms and signs. Condition 6: General symptoms and signs. Condition 7: General symptoms and signs. Condition 8: General symptoms and signs. Condition 9: General symptoms and signs. Condition 10: General symptoms and signs. Condition 11: General symptoms and signs. Condition 12: General symptoms and signs. Condi
Conditions
Interventions
For 50 patients, a central IV-line access will be inserted traditionally using landmarks.
Intervention 1: For other 50 patients, a central vein access will be inserted. Intervention 2: For 50 patients, a central IV-line access will be inserted traditionally using landmarks.
Diagnosis
For other 50 patients, a central vein access will be inserted.
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age>18 years; emergency admission; necessity for Central Intravenous access according to present attending; Exclusion criteria: Coagulation disorders; any contraindication for Central Access catheterization.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of Traditional CV-line Access. Timepoint: At the beginning of study. Method of measurement: Seconds.;Duration of ultrasonography-guided central intravenous access. Timepoint: At the beginning of study. Method of measurement: Seconds. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reason of using ultrasonography-guided central intravenous access. Timepoint: At the beginning of study. Method of measurement: Indication for CV line insertion. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarshid Farhadi,MD
Iran University of Medical Sciences
Outcome results
None listed